Proposed changes to appeal period for technology appraisal and highly specialised technologies appeals Methods / process manual consultation NICE process and methods 16 February 2025 Spesolimab for ...
Lawrence Lin; Executive Vice President and Chief Financial Officer; Azenta Inc Jacob Johnson; Analyst; Stephens Inc. Thank you, operator, and good afternoon to everyone on the line today. We would ...